Overview
- 154 inspections across 111 sites are on record.
- 316 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-10-01.
At a glance
Inspections
154
Sites
111
Observations
316
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Stanley Specialty Pharmacy Compounding and Wellness Center | 1 Oct 2021 | Human Drugs | View 483 → |
| King Bio Inc | 12 Aug 2021 | Human Drugs | View 483 → |
| N.V. Organon | 10 Sep 2019 | Human Drugs | |
| LEK Pharmaceuticals d.d. | 30 Aug 2019 | Human Drugs | |
| Charles River Laboratories, Inc. | 20 Aug 2019 | Human Drugs |
Sites inspected
Stanley Specialty Pharmacy Compounding and Wellness CenterCharlotte, United States1 insp.
King Bio IncAsheville, United States1 insp.
N.V. OrganonOss, Netherlands1 insp.
LEK Pharmaceuticals d.d.Lendava, Slovenia1 insp.
Charles River Laboratories, Inc.Charleston, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joseph F Owens7 shared
Steven M Weinman4 shared
Claudette D Brooks3 shared
Larry K Hampton3 shared
Sharna D Pratt3 shared
Susan W Ting3 shared
Jared P Stevens2 shared
Susan O Oladeji2 shared
Tamara J Henderson2 shared
Sonya M Edmonds2 shared
Full investigator report
Get the verbatim findings behind Bonita S Chester's 316 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site